In Italy, BMS fined €2.3M on antitrust charges

A fight over colostomy bags sounds like fodder for a bad joke, but Bristol-Myers Squibb isn't laughing: Italy's antitrust ministry has fined the company €2.3 million for restricting price competition for the bags. The Italian government says Bristol-Myers colluded with its competitors Coloplast, Hollister, and B Braun Milano--which also were fined--to keep prices up.

- read this report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.